Logo image
The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia
Journal article   Peer reviewed

The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia

Matthew R Olson, Stacey M Hartwig and Steven M Varga
The Journal of immunology (1950), Vol.181(11), pp.7958-7968
12/01/2008
DOI: 10.4049/jimmunol.181.11.7958
PMCID: PMC2587004
PMID: 19017987

View Online

Abstract

Children that were administered a formalin-inactivated respiratory syncytial virus (FI-RSV) vaccine experienced enhanced respiratory disease, including pulmonary eosinophilia, after contracting a natural RSV infection. RSV vaccine-enhanced disease can be mimicked in BALB/c mice immunized with either FI-RSV or with a recombinant vaccinia virus (vacv) expressing the RSV attachment (G) protein. We have recently demonstrated that memory CD8 T cells directed against the RSV immunodominant M2(82-90) epitope inhibit the development of pulmonary eosinophilia in either vacvG- or FI-RSV-immunized mice by reducing the total number of Th2 cells in the lung after RSV challenge. In this study, we show that memory CD8 T cells specific to a subdominant epitope within the RSV fusion (F) protein fail to inhibit the development of pulmonary eosinophilia after RSV challenge of mice previously co-immunized with vacvF and with either vacvG or FI-RSV. We observed that the inability of RSV F(85)-specific memory CD8 T cells to inhibit the development of pulmonary eosinophilia was largely due to an inadequate total number of F(85)-specific memory CD8 T cells in the lung at early times after RSV challenge. Increasing the number of F(85)-specific memory CD8 T cells after immunization grants these cells the ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia. Moreover, we demonstrate that RSV-specific memory CD8 T cells, when present in sufficient numbers, inhibit the production of the Th2-associated chemokines CCL17 and CCL22. Taken together, these results indicate that RSV-specific memory CD8 T cells may alter the trafficking of Th2 cells and eosinophils into the lung.
Respiratory Syncytial Virus Vaccines - immunology Humans Respiratory Syncytial Viruses - immunology Child, Preschool Epitopes, T-Lymphocyte - genetics Male Th2 Cells - immunology Immunologic Memory - drug effects Eosinophils - immunology Respiratory Syncytial Virus Infections - immunology Vaccinia virus - genetics Vaccinia virus - immunology Cell Movement - immunology Respiratory Syncytial Virus Vaccines - adverse effects Chemokine CCL22 - immunology Chemokine CCL17 - immunology Respiratory Syncytial Virus Infections - prevention & control Female Epitopes, T-Lymphocyte - immunology Child Immunologic Memory - immunology Disease Models, Animal Viral Envelope Proteins - genetics Mice, Knockout Vaccines, Inactivated - adverse effects Vaccines, Inactivated - immunology Animals Eosinophilia - immunology Respiratory Syncytial Viruses - genetics Eosinophilia - prevention & control Viral Envelope Proteins - immunology Mice Mice, Inbred BALB C CD8-Positive T-Lymphocytes - immunology Respiratory Syncytial Virus Vaccines - genetics Lung - immunology

Details

Metrics

Logo image